Biomedical Engineering Reference
In-Depth Information
63. Moy RL. Clinical presentation of actinic keratoses and squamous cell
carcinoma. J Am Acad Dermatol 2000; 42: 8-10.
64. Bäumler W, Wetzig T. Clinical application of fl uorescence diagnosis.
In: Goldman MP, Dover JS, Alam M, eds. Procedures in Cosmetic Der-
matology: Photodynamic Therapy, 2nd edn. Philadelphia, PA: Elsevier,
2008: 149-60.
65. Salasche SJ. Epidemiology of actinic keratoses and squamous cell car-
cinoma. J Am Acad Dermatol 2000; 42: 4-7.
66. Cockerell CJ. Histopathology of incipient intraepidermal squamous cell
carcinoma (“actinic keratosis”). J Am Acad Dermatol 2000; 42: 11-17.
67. Tschen EH, Wong DS, Pariser DM, et al. Photodynamic therapy using
aminolaevulinic acid for patients with nonhyperkeratotic actinic kera-
toses of the face and scalp: phase IV mulicentre clinical trial with
12-month follow up. Br J Dermatol 2006; 155: 1262-9.
68. Jeffes EW, McCullough JL, Weinstein GD, et al. Photodynamic therapy
of actinic keratoses with topical aminolevulinic acid hydrochloride
and fl uorescent blue light. J Am Acad Dermatol 2001; 45: 96-104.
69. Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy
using topical methyl 5-aminolevulinate compared with cryotherapy
for actinic keratosis: a prospective, randomized study. J Am Acad Der-
matol 2002; 47: 258-62.
70. Kurwa HA, Yong-Gee SA, Seed PT, et al. A randomized paired com-
parison of photodynamic therapy and topical 5-fl uorouracil in the
treatment of actinic keratoses. J Am Acad Dermatol 1999; 41: 414-18.
71. Tierney EP, Eide MJ, Jacobsen G, Ozog D. Photodynamic therapy for
actinic keratoses: survey of patient perceptions of treatment satisfac-
tion and outcomes. J Cosmet Laser Ther 2008; 10: 81-6.
72. Goldman MP, Atkin DH. ALA/PDT in the treatment of actinic kerato-
sis: spot versus confl uent therapy. J Cosmet Laser Ther 2003; 5: 107-10.
73. Alexiades-Amenakas MR, Geronemus RG. Laser-mediated photody-
namic therapy of actinic keratoses. Arch Dermatol 2003; 139: 1313-20.
74. Kennedy JC, Pottier RH, Pross DC. Photodynamic thereapy with
endogenous protoporphyrin IX: basic priniciples and present clnical
experience. J Photochem Photobiol Biol B 1990; 6: 143-8.
75. Dijkstra AT, Majoie IML, van Dongen JWF, van Weelden H et al. Pho-
todynamic therapy with violet light and topical δ-aminolaevulinic acid
in the treatment of actinic keratosis, Bowen's disease and basal cell car-
cinoma. J Eur Acad Dermatol Venereol 2001; 15: 550-554.
76. Ross EV, Anderson RR. Laser-tissue interactions. In: Goldman MP, ed.
Cutaneous and Cosmetic Laser Surgery. Philadelphia, PA: Elsevier, 2006:
1-26.
77. Ormrod D, Jarvis B. Topical aminolevulinic acid HCl photodynamic
therapy. Am J Clin Dermatol 2000; 2: 133-9.
78. Piacquadio DJ, Chen DM, Farber HF, et al. Photodynamic therapy with
aminolevulinic acid topical solution and visible blue light ini the treat-
ment of multiple actinic keratoses of the face and scalp: investigator-
blinded, phase 3, multicenter trials. Arch Dermatol 2004; 140: 41-6.
79. Gold MH. The evolving role of aminolevulinic acid hydrochloride
with photodynamic therapy in photoaging. Cutis 2002; 69: 8-13.
80. Fritsch C, Stege H, Saalmann G, et al. Green light is effective and less
painful than red light in photodynamic therapy of facial solar kerato-
ses. Photodermatol Photoimmunol Photomed 1997; 13: 181-5.
81. Smith S, Piacquadio D, Morhenn V, Atkin D. Short incubation PDT
versus 5-FU in treating actinic keratoses. J Drugs Dermatol 2003; 2:
629-35.
82. Jeffes WJ, McCullagh JL, Weinstein GD, et al. Photodynamic therapy of
actinic keratosis with topical 5-aminolaevulinic acid. Arch Dermatol
1997; 133: 727-32.
83. Nakano A, Tamada Y, Watanabe D, Ishida N et al. A pilot study to assess
teh effi cacy of photodynamic therapy for Japanese patients with actinic
keratosis in relation to lesion size and histological severity. Photoder-
matol Photoimmunol Photomed 2009; 25: 37-40.
84. Karrer S, Bäumler W, Abels C, et al. Long-pulse dye laser for photody-
namic therapy: investigations in vitro and in vivo. Lasers Surg Med
1999; 25: 51-9.
85. Itoh Y, Nineomiya Y, Henta T, et al. Topcal delta-aminolevulinic acid-
based photodynamic therapy for Japanese actinic keratoses. J Derma-
tol 2000; 27: 513-18.
86. Varma S, Wilson H, Kurwa HA, et al. Bowen's disease, solar keratoses
and superfi cial basal cell carcinomas treated by photodynamic therapy
using a large-fi eld incoherent light source. Br J Dermatol 2001; 144:
56-574.
87. Kim HS, Yoo JY, Cho KH, et al. Topical photodynamic therapy using
intense pulsed light for treatment of actinic keratosis: clinical and his-
topathologic evaluation. Dermatol Surg 2005; 31: 33-7.
88. Moseley H, Ibbotson S, Woods J, et al. Clinical and research applica-
tions of photodynamic therapy in dermatology: experience of the
Scottish PDT centre. Lasers Surg Med 2006; 38: 403-16.
89. Fink-Puches R, Hofer A, Smolle J, et al. Primary clinical response and
long-term follow-up of solar keratoses treated with topically applied
5-aminolevulinic acid and irradiation by different wave bands of light.
J Photochem Photobiol 1997; 41: 145-51.
90. Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy
using topical methyl 5-aminolevulinate compared with cryotherapy
for actinic keratosis: a prospective, randomized study. J Am Acad Der-
matol 2002; 47: 258-62.
91. Freeman M, Vinciullo C, Francis D, et al. A comparison of photody-
namic therapy using topical methyl aminolevulinate (Metvix) with
single cycle cryotherapy in patients with actinic keratosis: a prospec-
tive, randomized study. J Dermatolog Treat 2003; 14: 99-106.
92. Pariser DM, Lowe NJ, Stewart DM, et al. Photodynamic therapy with
topical methyl aminolevulinate for actinic keratosis: results of a pro-
spective randomized multicenter trial. J Am Acad Dermatol 2003; 48:
227-32.
93. Morton CA, Campbell S, Gupta G, et al. Intraindividual, right-left
comparison of topical methyl aminolaevulinate-photodynamic ther-
apy and cryotherapy in subjects with actinic keratoses: a multicentre,
randomized controlled study. Br J Dermatol 2006; 155: 1029-36.
94. Kaufmann R, Spelman L, Weightman W, et al. Multicentre intraindi-
vidual randomized trial of topical methyl aminolaevulinate photody-
namic therapy vs. cryotherapy for multiple actinic keratoses on the
extremities. Br J Dermatol 2008; 158: 994-9.
95. Kurwa HA, Yong-Gee SA, Seed PT, et al. A randomized paired com-
parison of photodynamic therapy and topical 5-fl uorouracil in the
treatment of actinic keratoses. J Am Acad Dermatol 1999; 41: 414-18.
96. Szeimies RM, Karrer S, Sauerwald A, Landthaler M. Photodynamic
therapy with topical application of 5-aminolevulinic acid in the treat-
ment of actinic keratoses: an initial clinical study. Dermatology 1996;
192: 246-51.
97. Tarstedt M, Rosdahl I, Berne B, Svanberg K, Wennberg AM. A random-
ized multicenter study to compare two treatment regimens of topical
methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face
and scalp. Acta Derm Venereol 2005; 85: 424-8.
98. Oseroff A. PDT as a cytotoxic agent and biological response modifi er:
implications for cancer prevention and treatment in immunosuppressed
and immunocompetent patients. J Invest Dermatol 2006; 126: 542-4.
99. Dragieva G, Prinz BM, Hafner J, et al. A randomized controlled clinical
trial of topical photodynamic therapy with methyl aminolaevulinate in
the treatment of actinic keratosis in transplant patients. Br J Dermatol
2004; 151: 196-200.
100. Perrett CM, McGregor JM, Warwick J, et al. Treatment of post-transplant
premalignant skin disease: a randomized intrapatient comparative study
of 5-fl uorouracil cream and topical photodynamic therapy. Br J Derma-
tol 2007; 156: 320-8.
101. Dragieva G, Hafner J, Dummer R, et al. Topical photodynamic therapy
in the treatment of actinic keratoses and Bowen's disease in transplant
recipients. Transplantation 2004; 17: 115-21.
102. de Graaf YGL, Kennedy C, Wolterbeek R, et al. Photodynamic therapy
does not prevent cutaneous squamous-cell carcinoma in organ-
transplant recipients: results of a randomized-controlled trial. J Invest
Dermatol 2006; 126: 569-74.
103. Vatve M, Ortonne JP, Birch-Machin MA, et al. Management of fi eld
change in actinic keratosis. Br J Dermatol 2007; 157: 21-4.
104. Szeimies RM, Matheson RT, Davis SA, et al. Topical Methyl aminolevu-
linate photodynamic therapy using red light-emitting diode light for
multiple actinic keratoses: a randomized study. Dermatol Surg 2009; 35:
586-92.
105. Serra-Guillen C, Nagore E, Hueso L, et al. A randomized comparative
study of tolerance and satisfaction in the treatment of actinic keratosis
of the face and scalp between 5% imiquimod cream and photodynamic
therapy with methylaminolaevulinate. Br J Dermatol 2011; 164: 429-33.
106. Palm MD, Goldman MP. Safety and effi cacy comparison of blue versus
red light sources for photodynamic therapy using methyl aminolevu-
linate in photodamaged skin. J Drugs Dermatol 2011; 10: 53-60.
